Trial intelligence / Profile preview

VIISTA: Insulin Analogs for Inpatient to Outpatient Transition

NCT00821795Phase 4Completed

Start
Mar 2009
Primary completion
Apr 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM). Started Mar 2009; status: completed.

02

Drugs

Insulin aspart + insulin aspart protamine
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00821795.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00821795.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call